WHO ICTRP trial
Allogeneic hematopoietic stem cell transpalntation using Thymoglobulin for…
JPRN-UMIN000015736 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000015736 |
|---|---|
| Public title | Allogeneic hematopoietic stem cell transpalntation using Thymoglobulin for patients with T-cell malignancy |
| Scientific title | Allogeneic hematopoietic stem cell transpalntation using Thymoglobulin for patients with T-cell malignancy - AlloHSCT with ATG for T-cell malignancy |
| Primary sponsor | National Cancer Center Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | T-cell malignancy |
| Interventions | Conditioning regimen using Thymoglobulin |
| Registration date | Nov 21, 2014 |
| Target size | 15 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: